Back to CITADEL ADVISORS LLC CITADEL ADVISORS LLC

FULCFULC
21 quarters

Position history for CITADEL ADVISORS LLCCITADEL ADVISORS LLC's holdings in FULCRUM THERAPEUTICS INC

CITADEL ADVISORS LLC holds 2.7M shares of FULC (FULCRUM THERAPEUTICS INC), worth $9.9M as of 2026-Q2. The position was increased (+109.3% shares). FULC represents 0.0% of CITADEL ADVISORS LLC's portfolio.

Current Value

$9.9M

Current Shares

2.7M

Total Value Change

+$5.6M

Total Shares Change

+2.3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.7M
+109.3%
$9.9M0.0%$3.66
45
2026-Q1
Increased
1.3M
+7.1%
$9.9M0.0%$7.87
30
2025-Q4
Increased
1.2M
+41.2%
$13.7M0.0%$11.34
37
2025-Q3
Increased
854,556
+414.1%
$7.9M0.0%$8.67
44
2025-Q2
Decreased
166,234
-55.6%
$1.1M0.0%$7.10
0
2025-Q1
Increased
374,256
+12.3%
$1.1M0.0%$3.01
28
2024-Q4
Decreased
333,323
-75.3%
$1.6M0.0%$4.68
0
2024-Q3
Decreased
1.3M
-24.1%
$4.8M0.0%$3.77
0
2024-Q2
Increased
1.8M
+34.1%
$11M0.0%$6.20
36
2024-Q1
Decreased
1.3M
-5.6%
$12.5M0.0%$9.44
0
2023-Q4
Increased
1.4M
+11.9%
$9.5M0.0%$6.75
31
2023-Q3
Decreased
1.3M
-16.6%
$5.6M0.0%$4.44
0
2023-Q2
Increased
1.5M
+618.4%
$5M0.0%$3.20
43
2023-Q1
Decreased
209,459
-74.3%
$596,9580.0%$2.83
0
2022-Q4
Increased
816,244
+27.1%
$5.9M0.0%$7.28
34
2022-Q3
Increased
642,132
+1045.7%
$5.2M0.0%$7.79
44
2022-Q2
Decreased
56,047
-50.0%
$275,0000.0%$4.95
0
2022-Q1
Decreased
112,203
-34.4%
$2.7M0.0%$22.38
0
2021-Q4
Decreased
170,961
-45.5%
$3M0.0%$17.05
0
2021-Q3
Decreased
313,910
-23.5%
$8.9M0.0%$27.79
0
2021-Q2
New
410,525
-
$4.3M0.0%$9.51
37

Other major holders of FULC: RA CAPITAL MANAGEMENT, L.P., RTW INVESTMENTS, LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used